2023 International Congress » Parkinson's Disease and Lewy Body Dementia

Meeting: 2023 International Congress

A multicenter, matched case-control study of alpha-synuclein accumulation in the gastrointestinal tract of Parkinson’s disease

C. Shin, S. Kim, SH. Park, JM. Kim, JY. Lee, SJ. Chung, JW. Kim, TB. Ahn, KW. Park, JH. Shin, CY. Lee, HJ. Lee, SH. Kong, YS. Suh, HK. Yang, HJ. Kim, B. Jeon (Sejong-si, Republic of Korea)

A Systematic Review of the Type, Timing, Frequency and Durability of Effect in Parkinson’s Disease Physical Therapy

M. El Hayek, J. Jofili Lopes, J. Lelaurin, A. Abi Nehme, K. Au, M. Okun, R. Salloum (Gainesville, USA)

A vicious cycle of karyopherin abnormalities in synucleinopathies

D. Sharipov, E. Bereczki, R. Killick, T. Hortobagyi, C. Troakes, D. Aarsland, F. Hirth (London, United Kingdom)

An Algorithmic Approach to Assessing Cognitive Functioning in Individuals with REM Sleep Behavior Disorder

G. Schneider, A. Avidan, D. Bliwise, S. Criswell, E. During, J. Elliott, L. Forsberg, J-F. Gagnon, M. Howell, D. Huddleston, A. Keil, J. Lee-Iannotti, M. Lim, J. Mcleland, M. Miglis, E. Mignot, R. Postuma, C. Schenck, D. Shprecher, E. ST. Louis, A. Videnovic, B. Boeve, Y-E. Ju, J. Fields (Rochester, USA)

Are patients presenting earlier in time? Secular changes in REM sleep behavior disorder

S. Joza, A. Stefani, A. Iranzo, J. Montplaisir, B. Högl, A. Pelletier, A. Ibrahim, JF. Gagnon, R. Postuma (Montreal, Canada)

Building a consensus conceptual model of meaningful symptoms and impacts in early Parkinson’s disease

J. Adams, J. Mammen, C. Kopil, Y. Xiao, D. Stephenson, T. Simuni (Rochester, USA)

Can a single-session of weight-shift training support people with Parkinson’s step from a freeze?

Y. Russo, P. Leveridge, J. Ye, Z. Wang, M. Wilson, A. Nieuwboer, S. Lamb, E. Kal, M. Norris, W. Young (Exeter, United Kingdom)

Chronotropic incompetence – a possible marker of severe Parkinson’s disease phenotype?

M. Andréasson, P. Svenningsson (Stockholm, Sweden)

Clinical characteristics of patients with dementia with Lewy bodies followed in a movement disorder clinic

AS. Jakobsson, L. Salvesen, AM. Hejl (Copenhagen, Denmark)

Clinical progression in males and females with early treatment-naive Parkinson’s disease

T. Kassuba, B. Ribba, T. Simuni, K. Marek, A. Siderowf, L. Chahine, M. Picillo, P. Brundin, G. Pagano (Basel, Switzerland)

Clinical-based diagnosis and self-reported Parkinson’s disease in a population-based sample in southern Brazil

G. Pereira, N. Soares, G. Marconi, C. Sangali, I. Pasuch, C. Bertocchi, N. Bruscato, J. Senger, A. Schumacher-Schuh, C. Rieder (Porto Alegre, Brazil)

Current practices for ‘timing’ of physical therapy in Parkinson’s Disease: ‘Burst vs. Spaced’

J. Lelaurin, R. Salloum, M. Okun (Gainesville, USA)

Early versus late levodopa administration in Parkinson’s disease: Comparative study

A. Akid, I. Kacem, A. Guedi, Y. Abida, S. Mrabet, A. Souissi, A. Gharbi, A. Nasri, R. Gouider (Tunis, Tunisia)

Exploring patient-physician communication in Parkinson’s disease management: a qualitative analysis

A. Pilotto, L. Tonges, J. Pagonabarraga (Brescia, Italy)

Falls in Mild Cognitive Impairment with Lewy bodies (MCI-LB).

E. Lirani Silva, S. Waite, C. Hamilton, P. Donaghy, J. O'Brien, J. Taylor, J. Lloyd, L. Allan, M. Firbank, A. Thomas, A. Yarnall (Newcastle, United Kingdom)

How does a diagnosis of Dementia with Parkinson’s influence future care provision?

B. Mohamed, A. Rafeeq, J. Adenwalla, C. Thomas, S. Page, R. Lewis-Morton, T. Williams, S. Mahon (cardiff, United Kingdom)

Longitudinal free-water changes in dementia with Lewy bodies

S. Chiu, R. Chen, W. Wang, M. Armstrong, B. Boeve, K. Kantarci, D. Vaillancourt (Gainesville, USA)

Myocardial sympathetic denervation biomarkers for early detection of prodromal DLB

M. Park, J. An (Daegu, Republic of Korea)

Nucleus basalis of Meynert and total gray matter atrophy are related to cognitive and gait decline in Parkinson’s disease

A. Yeung, F. Ba, M. Gee, R. Camicioli (Edmonton, Canada)

Olfactory discrimination ability is associated with subjective lack of social support in female Parkinson’s patients

T. Blum, L. Consortium, R. Dodel (Essen, Germany)

parkinson’s disease and coffee: is high consumption a protective factor or aversion to coffee taste a risk factor?

G. Procópio, C. Lobo, H. Dourado, MA. Silveira, AE. Lima, I. Oliveira, L. de Almeida, G. Valença (Salvador, Brazil)

Parkinson’s disease (PD) progression is associated with past exposure to organic contaminants in water at Marine Corps Base Camp Lejeune

S. Goldman, F. Weaver, B. Gonzalez, K. Stroupe, L. Cao, K. Colletta, E. Brown, C. Tanner (San Francisco, USA)

Parkinson’s disease-specific cortical atrophy as an independent contributor to motor symptom in Parkinson’s disease

SW. Kang, HS. Yoo, CL. Lyoo (Seoul, Republic of Korea)

Potentially inappropriate medication useage among patients newly diagnosed with dementia with Lewy bodies

K. Wyman-Chick, E. Chrenka, M. Barrett, M. Miller, L. Sargent, J. Kuntz, H. Nguyen, A. Werner, Z. Libert, R. Rossom (St Paul, USA)

Reaching the hard-to-reach: the representativeness of patients with parkinsonism recruited to the PRIME-UK cross-sectional study

E. Tenison, M. Smith, D. Pendry-Brazier, A. Cullen, F. Lithander, Y. Ben-Shlomo, E. Henderson (Bristol, United Kingdom)

The Synuclein-One Study: Detection of Cutaneous Phosphorylated alpha-synuclein for the Diagnosis of the Synucleinopathies

R. Freeman, T. Levine, J. Stohl, B. Bellaire, C. Gibbons (BOSTON, USA)

Utility of quantitative EEG during sleep as a potential biomarker of Lewy body disease progression

E. Matar, K. Ehgoetz Martens, R. Grunstein, A. D'Rozario, S. Lewis (Sydney, Australia)

Widespread Synuclein pathology in hyposmics precedes dopamine transporter deficit in PARS

K. Marek, D. Russell, L. Concha, C. Caspell-Garcia, E. Brown, M. Brumm, C. Choi, M. Stern, D. Jennings, C. Soto, A. Siderowf (New Haven, USA)

« View all sessions from the 2023 International Congress.